Skip to main content

VALIDACION FUNCIONAL DE VARIANTES EN EL GENOMA MITOCONDRIAL Y NUCLEAR EN PACIENTES CON PATOLOGIA MITOCONDRIAL

PI19/01772

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

  • Carreño Gago, Lidia
  • Juarez-Flores, Diana Luz|||0000-0003-3615-7803
  • Grau, Josep M.|||0000-0001-7560-224X
  • Ramón, Javier|||0000-0002-0673-9338
  • Lozano, Ester|||0000-0002-6307-9807
  • Vila-Julià, Ferran
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Garrabou, Glòria|||0000-0001-8973-9933
  • García Arumí, Elena|||0000-0003-1848-005X
Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome

  • Keraite, Ieva
  • Becker, Philipp
  • Canevazzi, Davide
  • Frías-López, Cristina
  • Dabad, Marc
  • Leno Colorado, Jorge
  • Abulí Vidal, Anna
  • García Arumí, Elena
  • Tonda, Raul
Data processing; DNA sequencing; Genomic analysis, Tratamiento de datos; Secuenciación de ADN; Análisis genómico, Tractament de dades; Seqüenciació d'ADN; Anàlisi genòmica, Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research., This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110 – EASI-Genomics (I.G.G.) and the ERC Synergy project BCLL@las under grant agreement No 810287 (I.G.G.). Institutional support was from the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofunded with ERDF funds (PI19/01772). We acknowledge the institutional support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and institutional co-financing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme to the institute.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

  • Carreño Gago, Lidia
  • Juárez-Flores, DL
  • Grau, Josep Maria
  • Ramon Pasías, Javier Francisco
  • Lozano, Ester
  • Vila Julià, Ferran
  • Martí Seves, Ramón
  • García Arumí, Elena
  • Garrabou, Gloria
Síndrome de Pearson; Aminocil-ARNt sintetasa mitocondrial; Nova variant patògena, Síndrome de Pearson; Aminocil-ARNt sintetasa mitocondrial; Nueva variante patógena, Pearson’s syndrome; Mitochondrial aminocyl-tRNA synthetase; Novel pathogenic variant, Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T>C (p.(Ile464Thr)), that cause a missense variant in amino acid 464. We demonstrate the pathogenicity of these new variants associated with reduced YARS2 mRNA transcript, reduced mitochondrial protein translation and dysfunctional organelle function. These pathogenic variants are responsible for late onset MLASA, herein accompanied by pancreatic insufficiency, observed in both brothers, clinically considered as Pearson’s syndrome. Molecular study of YARS2 gene should be considered in patients presenting Pearson’s syndrome characteristics and MLASA related phenotypes., This work was supported by the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofounded with ERDF funds (Grant No. FIS PI15/01428, FIS PMP15/00025 PI18/00498, PI19/01772, and the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Clinical and Genetic Analysis of Patients With TK2 Deficiency

  • Ceballos, Francisco
  • Serrano-Lorenzo, Pablo
  • Bermejo-Guerrero, Laura
  • Blázquez, Alberto
  • Quesada-Espinosa, Juan Francisco
  • Amigo, Jorge
  • Marti, Ramon
  • Garcia-Arumi, Elena
Thymidine kinase 2 deficiency; Mitochondrial DNA; Underdiagnosis, Deficiència de timidina cinasa 2; ADN mitocondrial; Infradiagnòstic, Deficiencia de timidina quinasa 2; ADN mitocondrial; Infradiagnóstico, Objectives Thymidine kinase 2 deficiency (TK2d) is a rare autosomal recessive disorder that stems from a perturbation of the mitochondrial DNA maintenance. Nucleoside treatment has recently shown promise as a disease-modifying therapy. TK2d was initially associated with rapidly progressive fatal myopathy in children featuring mitochondrial DNA depletion. Subsequently, less severe variants of the disease were described, with onset of symptoms during adolescence or adulthood and associated with the presence of multiple mtDNA deletions. These less severe phenotypes have been reported in only 15% of the approximately 120 patients described worldwide. However, some reports suggest that these juvenile and adult-onset presentations may be more common. The objective of this study was to describe the clinical phenotype in a sample of patients from Spain. Methods This study includes 53 patients harboring biallelic TK2 pathogenic variants, compiling data retrospectively from 7 Spanish centers. We analyzed allele frequency, investigated the most recent common ancestor of core haplotypes, and used the Runs of Homozygosity approach to investigate variant coalescence. Results Symptom onset distribution revealed that 32 patients (60%) experienced symptoms beyond 12 years of age. Approximately 30% of patients died of respiratory insufficiency, while 56% of surviving patients needed mechanical ventilation. Genetic analysis identified 16 distinct variants in TK2. Two variants, p.Lys202del and p.Thr108Met, exhibited significantly higher prevalence in the Spanish population than that reported in gnomAD database (86-fold and 13-fold, respectively). These variants are estimated to have originated approximately 16.8 generations ago for p.Thr108Met and 95.2 generations ago for p.Lys202del within the Spanish population, with the increase in frequency attributed to various forms of inbreeding. In late-onset cases, 46.9% carried the p.Lys202del variant. Discussion The higher frequency of TK2d in Spain can be partially attributed to the increased prevalence of 2 variants and consanguinity. Notably, in 60% of the cohort, the disease was late-onset, emphasizing the potential underdiagnosis of this subgroup of patients in other regions. Raising awareness of this potentially treatable disorder is of utmost importance because early interventions can significantly affect the quality of life and survival of affected individuals., This research was funded by the Instituto de Salud Carlos III, (ISCIII) and the Ministerio de Ciencia e Innovación (Madrid, Spain; cofunded by European Regional Development Fund “A way to make Europe”), grant number PI22/01587, to C.D.-G., PI19/01772 to E.G.-A. and PI21/00381 to M.A.M.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Leigh syndrome associated with TRMU gene mutations

  • Sala Coromina, Julia
  • de las Heras, Javier
  • Lasa Aranzasti, Amaia
  • García Arumí, Elena
  • Carreño Gago, Lidia
  • Arranz Amo, José Antonio
  • Carnicer Cáceres, Clara
  • Sánchez-Montáñez García-Carpintero, Ángel
  • del Toro Riera, Mireia
  • Dougherty-de Miguel, Lucia
Insuficiència hepàtica aguda: Síndrome de Leigh; TRMU, Insuficiencia hepática aguda; Síndrome de Leigh; TRMU, Acute liver failure; Leigh syndrome; TRMU, tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) deficiency causes an early onset potentially reversible acute liver failure, so far reported in less than 30 patients. We describe two new unrelated patients with an acute liver failure and a neuroimaging compatible with Leigh syndrome (LS) due to TRMU deficiency, a combination not previously reported. Our report enlarges the phenotypical spectrum of TRMU disease., This work was partially supported by the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofounded with ERDF funds (Grant No. FIS PI15/01428, PI19/01772).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

  • Bujan, Nuria
  • Morén, Constanza|||0000-0001-6848-7407
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Blázquez, Alberto|||0000-0002-6479-3615
  • Carnicer, Clara
  • Cortés Rodríguez, Ana Belén|||0000-0003-0675-6485
  • González, Cristina
  • López-Gallardo, Ester
  • Lozano, Ester|||0000-0002-6307-9807
  • Moliner, Sonia
  • Gort, Laura|||0000-0003-4746-1034
  • Tobías, Ester|||0000-0002-9968-3651
  • Delmiro, Aitor
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Fernández-Moreno, Miguel Ángel|||0000-0002-3461-0726
  • Ruiz-Pesini, Eduardo|||0000-0002-0269-7337
  • García Arumí, Elena|||0000-0003-1848-005X
  • Rodríguez Aguilera, Juan Carlos|||0000-0002-3371-4128
  • Garrabou, Glòria|||0000-0001-8973-9933
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

A method for multiplexed full-length single-molecule sequencing of the human mitochondrial genome

  • Keraite, Ieva
  • Becker, Philipp
  • Canevazzi, Davide
  • Frías-López, Cristina
  • Dabad, Marc
  • Leno Colorado, Jorge
  • Abulí Vidal, Anna
  • García Arumí, Elena
  • Tonda, Raul
Data processing; DNA sequencing; Genomic analysis, Tratamiento de datos; Secuenciación de ADN; Análisis genómico, Tractament de dades; Seqüenciació d'ADN; Anàlisi genòmica, Methods to reconstruct the mitochondrial DNA (mtDNA) sequence using short-read sequencing come with an inherent bias due to amplification and mapping. They can fail to determine the phase of variants, to capture multiple deletions and to cover the mitochondrial genome evenly. Here we describe a method to target, multiplex and sequence at high coverage full-length human mitochondrial genomes as native single-molecules, utilizing the RNA-guided DNA endonuclease Cas9. Combining Cas9 induced breaks, that define the mtDNA beginning and end of the sequencing reads, as barcodes, we achieve high demultiplexing specificity and delineation of the full-length of the mtDNA, regardless of the structural variant pattern. The long-read sequencing data is analysed with a pipeline where our custom-developed software, baldur, efficiently detects single nucleotide heteroplasmy to below 1%, physically determines phase and can accurately disentangle complex deletions. Our workflow is a tool for studying mtDNA variation and will accelerate mitochondrial research., This research has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824110 – EASI-Genomics (I.G.G.) and the ERC Synergy project BCLL@las under grant agreement No 810287 (I.G.G.). Institutional support was from the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofunded with ERDF funds (PI19/01772). We acknowledge the institutional support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and institutional co-financing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme to the institute.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

  • Carreño Gago, Lidia
  • Juárez-Flores, DL
  • Grau, Josep Maria
  • Ramon Pasías, Javier Francisco
  • Lozano, Ester
  • Vila Julià, Ferran
  • Martí Seves, Ramón
  • García Arumí, Elena
  • Garrabou, Gloria
Síndrome de Pearson; Aminocil-ARNt sintetasa mitocondrial; Nova variant patògena, Síndrome de Pearson; Aminocil-ARNt sintetasa mitocondrial; Nueva variante patógena, Pearson’s syndrome; Mitochondrial aminocyl-tRNA synthetase; Novel pathogenic variant, Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T>C (p.(Ile464Thr)), that cause a missense variant in amino acid 464. We demonstrate the pathogenicity of these new variants associated with reduced YARS2 mRNA transcript, reduced mitochondrial protein translation and dysfunctional organelle function. These pathogenic variants are responsible for late onset MLASA, herein accompanied by pancreatic insufficiency, observed in both brothers, clinically considered as Pearson’s syndrome. Molecular study of YARS2 gene should be considered in patients presenting Pearson’s syndrome characteristics and MLASA related phenotypes., This work was supported by the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofounded with ERDF funds (Grant No. FIS PI15/01428, FIS PMP15/00025 PI18/00498, PI19/01772, and the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Leigh syndrome associated with TRMU gene mutations

  • Sala Coromina, Julia
  • de las Heras, Javier
  • Lasa Aranzasti, Amaia
  • García Arumí, Elena
  • Carreño Gago, Lidia
  • Arranz Amo, José Antonio
  • Carnicer Cáceres, Clara
  • Sánchez-Montáñez García-Carpintero, Ángel
  • del Toro Riera, Mireia
  • Dougherty-de Miguel, Lucia
Insuficiència hepàtica aguda: Síndrome de Leigh; TRMU, Insuficiencia hepática aguda; Síndrome de Leigh; TRMU, Acute liver failure; Leigh syndrome; TRMU, tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) deficiency causes an early onset potentially reversible acute liver failure, so far reported in less than 30 patients. We describe two new unrelated patients with an acute liver failure and a neuroimaging compatible with Leigh syndrome (LS) due to TRMU deficiency, a combination not previously reported. Our report enlarges the phenotypical spectrum of TRMU disease., This work was partially supported by the Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias and cofounded with ERDF funds (Grant No. FIS PI15/01428, PI19/01772).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Clinical and Genetic Analysis of Patients With TK2 Deficiency

  • Ceballos, Francisco
  • Serrano-Lorenzo, Pablo
  • Bermejo-Guerrero, Laura
  • Blázquez, Alberto
  • Quesada-Espinosa, Juan Francisco
  • Amigo, Jorge
  • Marti, Ramon
  • Garcia-Arumi, Elena
Thymidine kinase 2 deficiency; Mitochondrial DNA; Underdiagnosis, Deficiència de timidina cinasa 2; ADN mitocondrial; Infradiagnòstic, Deficiencia de timidina quinasa 2; ADN mitocondrial; Infradiagnóstico, Objectives Thymidine kinase 2 deficiency (TK2d) is a rare autosomal recessive disorder that stems from a perturbation of the mitochondrial DNA maintenance. Nucleoside treatment has recently shown promise as a disease-modifying therapy. TK2d was initially associated with rapidly progressive fatal myopathy in children featuring mitochondrial DNA depletion. Subsequently, less severe variants of the disease were described, with onset of symptoms during adolescence or adulthood and associated with the presence of multiple mtDNA deletions. These less severe phenotypes have been reported in only 15% of the approximately 120 patients described worldwide. However, some reports suggest that these juvenile and adult-onset presentations may be more common. The objective of this study was to describe the clinical phenotype in a sample of patients from Spain. Methods This study includes 53 patients harboring biallelic TK2 pathogenic variants, compiling data retrospectively from 7 Spanish centers. We analyzed allele frequency, investigated the most recent common ancestor of core haplotypes, and used the Runs of Homozygosity approach to investigate variant coalescence. Results Symptom onset distribution revealed that 32 patients (60%) experienced symptoms beyond 12 years of age. Approximately 30% of patients died of respiratory insufficiency, while 56% of surviving patients needed mechanical ventilation. Genetic analysis identified 16 distinct variants in TK2. Two variants, p.Lys202del and p.Thr108Met, exhibited significantly higher prevalence in the Spanish population than that reported in gnomAD database (86-fold and 13-fold, respectively). These variants are estimated to have originated approximately 16.8 generations ago for p.Thr108Met and 95.2 generations ago for p.Lys202del within the Spanish population, with the increase in frequency attributed to various forms of inbreeding. In late-onset cases, 46.9% carried the p.Lys202del variant. Discussion The higher frequency of TK2d in Spain can be partially attributed to the increased prevalence of 2 variants and consanguinity. Notably, in 60% of the cohort, the disease was late-onset, emphasizing the potential underdiagnosis of this subgroup of patients in other regions. Raising awareness of this potentially treatable disorder is of utmost importance because early interventions can significantly affect the quality of life and survival of affected individuals., This research was funded by the Instituto de Salud Carlos III, (ISCIII) and the Ministerio de Ciencia e Innovación (Madrid, Spain; cofunded by European Regional Development Fund “A way to make Europe”), grant number PI22/01587, to C.D.-G., PI19/01772 to E.G.-A. and PI21/00381 to M.A.M.